Notably, we observed that FGF5 expression in tumor cells is downregulated after irradiation treatment, yet its overexpression or re-expression significantly enhances tumor cell migration, highlighting its complex involvement in NPC biology and treatment resistance. This evidence concerns the gene FGF5 and nasopharyngeal carcinoma.